Wong Shelly sold $1K of ALXO
Wong Shelly (SVP, FINANCE AND CAO) sold 573 shares of ALX ONCOLOGY HOLDINGS INC (ALXO) at $1.93 on 2026-08-17.
How this was made
The 30-second read
Why it matters
The only new information is the insider sale details (shares, price, total value, post-transaction holdings).
Market read
Traders may note the insider sale, but the disclosed value is small and does not introduce new fundamentals.
What to watch
The article does not state whether the sale was tax-related, diversified, or part of a broader pattern; it also notes no pre-arranged 10b5-1 plan, which can increase interpretive noise.
Background
The article is an SEC Form 4 insider transaction disclosure for ALX Oncology Holdings Inc.
Ticker impact
ALX Oncology disclosed an insider open-market sale by SVP Finance and CAO Wong Shelly of 573 shares at $1.93 on 2026-08-17.
Low likelihood of a sustained price move; any reaction is likely limited to short-term sentiment.
The filing is a small, disclosed insider sale (about $1.1k) and provides no new company-specific operational, financial, or regulatory information.
Market effects
No clear sector read-through from a small, routine insider sale.
None indicated.
None indicated.
Counterpoint
Insider sales can sometimes precede negative developments, but this filing lacks any accompanying new disclosure or material size.
Key entities
- issuerALX Oncology Holdings Inc
Subject of the Form 4 insider transaction disclosure.
- insiderWong Shelly
SVP, Finance and CAO who sold 573 shares in an open-market transaction.